Management of colorectal peritoneal metastases: Expert opinion - Institut Curie Accéder directement au contenu
Article Dans Une Revue Journal of Visceral Surgery Année : 2019

Management of colorectal peritoneal metastases: Expert opinion

Résumé

When peritoneal metastases are diagnosed (strong agreement of experts): (i) seek advice from a multidisciplinary coordination meeting (MCM) with large experience in peritoneal disease (e.g. BIG RENAPE network); (ii) transfer (or not) the patient to a referral center with experience in hyperthermic intraperitoneal chemotherapy (HIPEC), according to the advice of the MCM. With regard to systemic chemotherapy (strong agreement of experts): (i) it should be performed both before and after surgery, (ii) for no longer than 6 months; (iii) without postoperative anti-angiogenetic drugs. With regard to cytoreductive surgery (strong agreement of experts): (i) Radical surgery requires a xiphopubic midline incision; (ii) no cytoreductive surgery via laparoscopy. With regard to HIPEC: HIPEC can be proposed for trials outside an HIPEC referral center (weak agreement between experts): (i) if surgery is radical; (ii) if the expected morbidity is "reasonable"; (iii) if the indication for HIPEC was suggested by a MCM, and; (iv) mitomycin is preferred to oxaliplatin (which cannot be recommended) for this indication.
Fichier principal
Vignette du fichier
S1878788619301274.pdf (116.36 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03489199 , version 1 (20-07-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

K. Abboud, T. André, M. Brunel, M. Ducreux, C. Eveno, et al.. Management of colorectal peritoneal metastases: Expert opinion. Journal of Visceral Surgery, 2019, 156, pp.377 - 379. ⟨10.1016/j.jviscsurg.2019.08.002⟩. ⟨hal-03489199⟩
30 Consultations
36 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More